SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-006871
Filing Date
2018-03-27
Accepted
2018-03-27 16:53:00
Documents
2
Period of Report
2018-03-22
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ITEM 8.01 REGULATORY UPDATE atrs-8k_20180322.htm 8-K 42037
2 EX-99.1 PRESS RELEASE atrs-ex991_6.htm EX-99.1 16082
  Complete submission text file 0001564590-18-006871.txt   59517
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 18716027
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10